Coupling aminohexyl-FAD to proteins with dimethyladipimidate

Area of Science:

• Bioconjugation Chemistry
• Immunoassay Development
• Clinical Diagnostics

Background:

• Apoenzyme reactivation immunoassay systems (ARIS) require efficient protein labeling for optimal performance.
• Existing labeling methods can lead to protein self-crosslinking, reducing conjugate immunoreactivity.
• A robust and controllable method for conjugating N6-aminohexyl-flavin adenine dinucleotide (AHFAD) to proteins is needed.

Purpose of the Study:

• To develop and validate an efficient method for coupling AHFAD to proteins for ARIS applications.
• To demonstrate the utility of AHFAD-protein conjugates in a fully automated ARIS assay for thyroxin-binding globulin (TBG).

Main Methods:

• Activation of AHFAD with dimethyladipimidate, followed by gel filtration to remove excess reagent.
• Incubation of activated AHFAD with target proteins to form a stable conjugate, followed by purification.
• Development of a competitive protein-binding assay using the TBG-AHFAD conjugate and apoglucose oxidase for automated measurement.

Main Results:

• The labeling technique allows controlled incorporation of AHFAD, preventing self-crosslinking and preserving immunoreactivity.
• The automated ARIS assay for TBG demonstrated a clinically relevant range (0-60 mg/L) and high throughput (60 reactions/75 min).
• Regression analysis showed strong correlation (r=0.975) with a radioimmunoassay (RIA) method.

Conclusions:

• The described method provides an efficient and broadly applicable approach for preparing AHFAD-protein conjugates.
• AHFAD-protein conjugates are suitable for use in automated ARIS assays, offering accurate and rapid quantification of biomarkers like TBG.
• This labeling strategy enhances immunoassay development for various diagnostic applications.